Journals / Turkish Journal of Pediatrics / 2019 / Cilt: 61 - Sayı: 5

Serum Bcl-2, caspase-9 and soluble FasL levels as perinatal markers in late preterm pregnancies with intrauterine growth restriction

Pages
686–696
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

In conclusion, fetal complications arethought to be related to the severity of apoptosis in pregnancies complicatedwith IUGR.The aim of the study was to test the measurability of the severity of apoptosisusing Bcl-2, caspase-9, soluble Fas ligand (sFasL) markers and the maternalblood sample in addition to the diagnostic methods commonly used todiagnose IUGR; and to decrease the rates of adverse perinatal outcomes dueto IUGR and to evaluate the fetal well-being status without feeling a needfor invasive procedures.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Intrauterine growth restriction (IUGR) is the inability of the fetus to growand develop in the expected pattern.
📊
Key Findings & Data:It occurs in about 5% of pregnancies andis associated with severe fetal mortality and morbidity.
💡
Conclusion & Impact:In conclusion, fetal complications arethought to be related to the severity of apoptosis in pregnancies complicatedwith IUGR.The aim of the study was to test the measurability of the severity of apoptosisusing Bcl-2, caspase-9, soluble Fas ligand (sFasL) markers and the maternalblood sample in addition to the diagnostic methods commonly used todiagnose IUGR; and to decrease the rates of adverse perinatal outcomes dueto IUGR and to evaluate the fetal well-being status without feeling a needfor invasive procedures.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Özet

Intrauterine growth restriction (IUGR) is the inability of the fetus to growand develop in the expected pattern. It occurs in about 5% of pregnancies andis associated with severe fetal mortality and morbidity. Affected infants arealso highly vulnerable to diseases such as perinatal asphyxia, cerebral palsy,meconium aspiration syndrome, coagulation disorders, and immune systemdisorders that require long-term treatment. Apoptosis is thought to play a keyrole in the etiopathogenesis of IUGR. In conclusion, fetal complications arethought to be related to the severity of apoptosis in pregnancies complicatedwith IUGR.The aim of the study was to test the measurability of the severity of apoptosisusing Bcl-2, caspase-9, soluble Fas ligand (sFasL) markers and the maternalblood sample in addition to the diagnostic methods commonly used todiagnose IUGR; and to decrease the rates of adverse perinatal outcomes dueto IUGR and to evaluate the fetal well-being status without feeling a needfor invasive procedures. One hundred and fifty-nine late preterm pregnancieswere included in the study. Eighty were diagnosed with IUGR and the otherswere the control group. During delivery, maternal and umbilical cord bloodsamples were taken. Bcl-2, caspase-9, sFasL marker levels in maternal andumbilical cord sera were determined using ELISA method. Bcl-2 levels werefound to be significantly high in the maternal and umbilical cord sera in theIUGR group. There was also no significant difference between umbilical cordsera of the two groups in terms of sFasL and caspase-9 levels.The results suggest that maternal serum Bcl-2 levels may also be helpfulin the diagnosis of IUGR when used besides the ultrasonographic findings.Multicenter studies with large patient groups will increase knowledge in thisarea.

🔖

Cite This Article

GENÇ, Ş. Ö., KARAKUŞ, S., ÇETİN, A., ÇETİN, M., DOĞAN, H. O., KORGALI, E. Ü. (2019). Serum Bcl-2, caspase-9 and soluble FasL levels as perinatal markers in late preterm pregnancies with intrauterine growth restriction. Turkish Journal of Pediatrics, Cilt: 61 - Sayı: 5, 686–696. https://ajindex.com/articles/412073

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (15)

  1. Gardosi J, Madurasinghe V, Williams M, Malik A, Francis A. Maternal and fetal risk factors for stillbirth: population based study. BMJ 2013; 346: f108
  2. Robinson R. The fetal origins of adult disease. BMJ 2001; 322: 375-376
  3. Baschat AA. Neurodevelopment following fetal growth restriction and its relationship with antepartum parameters of placental dysfunction. Ultrasound Obstet Gynecol 2011; 37: 501-514
  4. Kadyrov M, Kingdom JCP, Huppertz B. Divergent trophoblast invasion and apoptosis in placental bed spiral arteries from pregnancies complicated by maternal anemia and early-onset preeclampsia/ intrauterine growth restriction. Am J Obstet Gynecol 2006; 194: 557-563
  5. Khashu M, Narayanan M, Bhargava S, Osiovich H. Perinatal outcomes associated with preterm birth at 33 to 36 weeks' gestation: A population-based cohort study. Pediatrics 2009; 123: 109-113
  6. Martin JA, Hamilton BE, Sutton PD, et al; Centers for Disease Control and Prevention National Center for Health Statistics National Vital Statistics System. Births: final data for 2005. Natl Vital Stat Rep 2007; 56: 1-103
  7. Dawes GS, Moulden M, Redman CW. Short-term fetal heart rate variation, decelerations, and umbilical flow velocity waveforms before labor. Obstet Gynecol 1992; 80: 673-678
  8. Chauhan SP, Sanderson M, Hendrix NW, Magann EF, Devoe LD. Perinatal outcome and amniotic fluid index in the antepartum and intrapartum periods: A meta-analysis. Am J Obstet Gynecol 1999; 181: 1473- 1478
  9. Alfirevic Z, Neilson JP. Doppler ultrasound for fetal assessment in high risk pregnancies. Cochrane Database Syst Rev 2010; 1: CD000073
  10. Westergaard HB, Langhoff-Roos J, Lingman G, Marsal K, Kreiner S. A critical appraisal of the use of umbilical artery Doppler ultrasound in high-risk pregnancies: use of meta-analyses in evidence-based obstetrics. Ultrasound Obstet Gynecol 2001; 17: 466- 476
  11. Boers KE, Bijlenga D, Mol BW, et al. Disproportionate intrauterine growth intervention trial at term: DIGITAT. BMC Pregnancy Childbirth 2007; 7: 12
  12. Fenton TR, Kim JH. A systematic review and metaanalysis to revise the Fenton growth chart for preterm infants. BMC Pediatr 2013; 13: 59
  13. Kaufmann P, Black S, Huppertz B. Endovascular trophoblast invasion: implications for the pathogenesis of intrauterine growth retardation and preeclampsia. Biol Reprod 2003; 69: 1-7
  14. Roberts JM, Escudero C. The placenta in preeclampsia. Pregnancy Hypertens 2012; 2: 72-83
  15. Gluckman PD, Harding JE. The physi